top of page

About
Paint is committed to advancing its delivery technology and building a pipeline of tissue-targeted therapeutics. The modular PAINTR™ discovery platform has identified targeted delivery motifs for multiple tissues.

Company Overview
Meet The Team
With over 20 years of collaborative experience, the Paint team brings unparalleled expertise in drug discovery and development. Uniquely positioned to develop groundbreaking technologies like PulmoPaint™, CerebroPaint™, and GastroPaint™, we are revolutionizing how medicines are delivered and retained in specific tissues.

View Bio

Eric Springman, PhD
Co-Founder & COO

View Bio

Frank Guarnieri, PhD
Co-Founder, & CSO

View Bio

Mariah Stewart, PhD
Scientific Program Advisor

View Bio

Ron Sarkar, PhD, MBA
BD Consultant

View Bio

Dani Stoltzfus, PhD
R&D Consultant


bottom of page